Bloomios, Inc. (BLMS)

Market Cap	6.79K -99.9%
Revenue (ttm)	8.23M +46.5%
Net Income	-39.61M
EPS	-1.76
Shares Out	67.87M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	500,000
Average Volume	1,037,714
Open	0.0001
Previous Close	0.0001
Day's Range	0.0001 - 0.0001
52-Week Range	0.0001 - 0.0001
Beta	-0.53
RSI	37.88
Earnings Date	Apr 17, 2026

About Bloomios

Bloomios, Inc. manufactures, markets, and distributes cannabidiol products. The company’s product categories include edibles, tinctures, oils, salves, capsules, balms, lotions, creams, beverages, and pet treats. It sells its hemp derived supplements and cosmetic products through wholesale and retail distribution channels. The company was formerly known as XLR Medical Corp. and changed its name to Bloomios, Inc. in April 2021. Bloomios, Inc. was incorporated in 2001 and is headquartered in Santa Barbara, California.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2001
• Country: United States
• Stock Exchange: OTCMKTS
• Ticker Symbol: BLMS

Financial Performance

In 2022, Bloomios's revenue was $6.08 million, a decrease of -28.43% compared to the previous year's $8.49 million. Losses were -$13.77 million, 584.8% more than in 2021.